IGF1 and acromegaly: With the increased availability and accessibility of new treatment options, including oral octreotide capsules (Mycapssa®) for GH and IGF-1 management in patients with acromegaly, it is imperative that clinicians continue to improve diagnostic measures to seek earlier diagnosis, rapid onset of treatment, and earlier hormone suppression in acromegaly patients, especially females.